|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Inflexxion National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00020553 |
Purpose
RATIONALE: A videotape support program may help families improve communication and coping skills when a parent is diagnosed with cancer.
PURPOSE: Randomized trial to study the effectiveness of a video support program for families who have a parent who has been newly diagnosed with cancer.
| Condition | Intervention |
|
Cancer-Related Problem/Condition |
Procedure: psychosocial assessment and care |
| MedlinePlus related topics: | Cancer |
| Study Type: | Interventional |
| Study Design: | Other |
| Official Title: | We Can Cope: Family Support When A Parent Has Cancer |
| Study Start Date: | August 2000 |
OBJECTIVES: I. Determine if families who participate in a video support program function better as a family in the areas of communication, togetherness, and overall increased ability to cope when a parent is newly diagnosed with cancer. II. Determine if participation in this program decreases stress-related illness in the well members of the family. III. Determine the safety of this program. IV. Determine patient/family and medical provider satisfaction with this program.
OUTLINE: This a randomized study. Adult parent participants and spouses undergo a baseline assessment over approximately 1 hour comprising completion of a self-assessment form followed by an interview. Families are then randomized to one of two arms. Arm I: Adult parent participants receive a video support program comprising 3 videotapes (parent tape, adolescent tape, and child tape) and a parent guidebook. The parents are encouraged to screen the videotapes and decide whether to have their child and/or adolescent view the program. Arm II: Adult parent participants receive no video support material. Families may view the video program after study completion. Adult parent participants in both arms complete follow-up assessments at 6 and 12 weeks. This clinical trial is being conducted at the locations listed below. If you are interested in this clinical trial but unable to visit these locations, please call #1-800-848-3895 ext. 226 and ask for more information about the We Can Cope study.
PROJECTED ACCRUAL: A total of 230 families will be accrued for this study.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS: Parent with a first diagnosis of cancer within the past 5 years No recurrence of a previously diagnosed cancer Must have at least 1 child between the ages of 6 and 18 Ill parent must live with child/children at least 50% of the time No plans to move out-of-state within the next 3 months
PATIENT CHARACTERISTICS: Age: See Disease Characteristics Any age Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: No psychotic disorder (such as schizophrenia) or a brain/psychiatric disorder due to disease/illness
PRIOR CONCURRENT THERAPY: Not specified
Contacts and Locations| United States, Maine | |||||
| Maine Center for Cancer Medicine and Blood Disorders | |||||
| Scarborough, Maine, United States, 04074 | |||||
| United States, Massachusetts | |||||
| Inflexxion | |||||
| Newton, Massachusetts, United States, 02464-1594 | |||||
| United States, New York | |||||
| Albert Einstein Comprehensive Cancer Center | |||||
| Bronx, New York, United States, 10461 | |||||
| United States, North Carolina | |||||
| Buddy Kemp Caring House | |||||
| Charlotte, North Carolina, United States, 28207 | |||||
| United States, Texas | |||||
| Baylor University Medical Center | |||||
| Dallas, Texas, United States, 75246 | |||||
| Inflexxion |
| National Cancer Institute (NCI) |
| Study Chair: | Jonas I. Bromberg | Inflexxion |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000068602, INFLEXXION-000080, ITS-000080, NCI-V01-1659 |
| First Received: | July 11, 2001 |
| Last Updated: | October 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00020553 |
| Health Authority: | United States: Federal Government |
|